or Try an Advanced Search...

    Technical Analysis for EMBC - Embecta Corp.

    Grade Last Price % Change Price Change
    C 13.82 -1.29% -0.18
    EMBC closed down 1.29 percent on Friday, November 22, 2024, on 79 percent of normal volume. It ran into resistance at its 50 day moving average.
    2 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Up Down Down
    Historical EMBC trend table...
    Date Alert Name Type % Chg
    50 DMA Resistance Bearish 0.00%
    Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 0.00%
    Outside Day Range Expansion 0.00%
    Oversold Stochastic Weakness 0.00%
    MACD Bearish Centerline Cross Bearish -1.29%
    Oversold Stochastic Weakness -1.29%
    Crossed Above 200 DMA Bullish 1.54%
    Stochastic Reached Oversold Weakness 1.54%
    Earnings Movers Other 1.54%
    Inside Day Range Contraction 1.54%
    Older End-of-Day Signals for EMBC ...

       Recent Intraday Alerts

    Alert Time
    Outside Day about 13 hours ago
    Down 3% about 13 hours ago
    Fell Below Previous Day's Low about 13 hours ago
    Down 2 % about 13 hours ago
    Down 1% about 14 hours ago
    View Earlier Intraday Alerts

    Get a Trading Sidekick!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Read My Charts!
    Configure default chart indicators
    EMBC Chart by TradingView
    Basic chart:

    Profile

    Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety devices, as well as digital applications to assist people with managing their diabetes. The company primarily sells its products to wholesalers and distributors in the United States and internationally. Embecta Corp. was founded in 1924 and is based in Parsippany, New Jersey.
    Classification
    Sector: Healthcare
    Industry: Drug Manufacturers - Specialty & Generic
    Keywords: Diabetes Medical Equipment Medical Device Syringe Drug Paraphernalia

    Is EMBC a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 1 bullish, 1 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Nov 18 Inside a $400 billion bet on the brain-computer interface revolution
    Nov 12 UPDATE - embecta to Report Fiscal Fourth Quarter and Full Year 2024 Financial Results
    Nov 12 embecta to Report Fiscal Fourth Quarter and Full Year 2024 Financial Results
    Nov 7 embecta Celebrates National Diabetes Awareness Month by Ringing Nasdaq Closing Bell
    Sep 22 Embecta Corp.: Navigating Through A Changing Landscape
    Sep 4 Embecta Stock Gains on FDA Clearance for Type 2 Diabetes Insulin Pump
    Sep 3 Embecta gets FDA clearance for type 2 diabetes patch pump
    Sep 3 Embecta gets FDA nod for insulin patch pump
    Sep 3 embecta Announces FDA Clearance of its Disposable Patch Pump for Insulin Delivery Informed by the Unique Needs of People with Type 2 Diabetes
    Aug 16 Embecta (NASDAQ:EMBC) Is Posting Promising Earnings But The Good News Doesn’t Stop There
    See more EMBC news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 19.1578
    52 Week Low 9.7079
    Average Volume 340,168
    200-Day Moving Average 13.44
    50-Day Moving Average 14.38
    20-Day Moving Average 14.68
    10-Day Moving Average 14.57
    Average True Range 0.70
    RSI (14) 43.18
    ADX 17.86
    +DI 18.49
    -DI 25.09
    Chandelier Exit (Long, 3 ATRs) 14.26
    Chandelier Exit (Short, 3 ATRs) 15.16
    Upper Bollinger Bands 16.20
    Lower Bollinger Band 13.17
    Percent B (%b) 0.21
    BandWidth 20.61
    MACD Line -0.09
    MACD Signal Line 0.10
    MACD Histogram -0.1867
    Fundamentals Value
    Market Cap 795.67 Million
    Num Shares 57.6 Million
    EPS 0.96
    Price-to-Earnings (P/E) Ratio 14.40
    Price-to-Sales 0.83
    Price-to-Book 2.61
    Dividend 0.60
    Dividend Yield 4.34%
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 15.19
    Resistance 3 (R3) 15.22 14.81 14.96
    Resistance 2 (R2) 14.81 14.46 14.79 14.88
    Resistance 1 (R1) 14.31 14.24 14.11 14.28 14.81
    Pivot Point 13.90 13.90 13.79 13.88 13.90
    Support 1 (S1) 13.40 13.55 13.20 13.37 12.83
    Support 2 (S2) 12.99 13.33 12.97 12.76
    Support 3 (S3) 12.49 12.99 12.68
    Support 4 (S4) 12.46